ACIU — AC Immune SA Share News
0.000.00%
Last trade - 00:00- $260.54m
- $173.47m
- CH₣3.57m
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Rivian, Biohaven, CervoMed
Brief: AC Immune Presents First In Vivo Images Of Brain Tdp-43 Pathology From Phase 1 Trial Of Pet Tracer Aci-19626, At Ad/Pdtm 2026
U.S. STOCKS ON THE MOVE-Alibaba, Accenture, energy companies
AC Immune rises as early data shows new brain scan can spot dementia protein
Swiss stocks - Factors to watch on March 11
Brief: AC Immune Initiates Phase 1 Clinical Trial Of NLRP3 Inhibitor
Brief: Ac Immune Says Informed Enrollment Has Been Temporarily Paused For Phase 2B Retain Trial
U.S. STOCKS ON THE MOVE-Walt Disney, Titan Mining, Costco Wholesale
U.S. STOCKS ON THE MOVE-Nordson, Walt Disney, Titan Mining
U.S. STOCKS ON THE MOVE-Roku, Ciena, Diamond Hill
AC Immune jumps after Parkinson's treatment shows promise in mid-stage study
Brief: AC Immune Positive Interim Phase 2 Data On ACI-7104.056 Support Potential Slowing Of Progression Of Parkinson’s Disease
NASDAQ RESUMED AT 07:30 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
AC Immune SA reports results for the quarter ended June 30 - Earnings Summary